Trial
NCT00680316
A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Genentech, Inc.
Collaborators
—
Condition
Cystic Fibrosis
Intervention
Dornase alfa
Why stopped
Most patients were unable to perform the test being used to measure lung function, thus it became clear the study would not yield clinically meaningful data
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-12